Podcast appearances and mentions of Clyde W Yancy

Clyde W. Yancy, MD, MSc, discusses “Heart Failure in African American Individuals, Version 2.0,” his editorial recently published in JAMA. He emphasizes the importance of understanding genetic factors in predicting and managing heart failure in African American people, as well as the implications for genetic screening. Dr. Yancy highlights ways to address health disparities in cardiovascular care that Northwestern Medicine Bluhm Cardiovascular Institute is putting into practice.

The US Black population experienced more than 80 million excess years of life lost compared with the White population over a recent 22-year period. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, discusses the research that quantified this disparity with authors César Caraballo, MD, Harlan M. Krumholz, MD, SM, and Clyde W. Yancy, MD, MSc. Related Content: Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020

Interview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc. Related Content: Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials Is There a Role for Renal Denervation in the Treatment of Hypertension?

Interview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc. Related Content: Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials Is There a Role for Renal Denervation in the Treatment of Hypertension?

Interview with Ambarish Pandey, MD, MSCS, author of Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure, and Eldrin F. Lewis, MD, MPH, author of Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure. Hosted by Clyde W. Yancy, MD. Related Content: Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure

Interview with Ambarish Pandey, MD, MSCS, author of Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure, and Eldrin F. Lewis, MD, MPH, author of Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure. Hosted by Clyde W. Yancy, MD. Related Content: Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure

Interview with Lisa Rotenstein, MD, MBA, author of A Learning Health System Agenda for Organizational Approaches to Enhancing Occupational Well-being Among Clinicians, and Clyde W. Yancy, MD, author of Resident Physician Wellness Postpandemic: How Does Healing Occur?. Hosted by JAMA Associate Editor Anne Cappola, MD.

In recognition of Black History Month, AMA's CXO Todd Unger, is joined by Clyde Yancy, MD, MSc, vice dean of diversity and inclusion and chief of the Division of Cardiology at Northwestern University's Feinberg School of Medicine in Chicago to discuss the importance of recognizing Black pioneers in medicine. The Kathy Blake, MD, MPH, and Clyde W. Yancy, MD, MSc, article "Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt" is available on JAMA Surgery (doi:10.1001/jamasurg.2021.5611).

In this interview, Clyde W. Yancy, MD, FACC, C. Noel Bairey Merz, MD, FACC and Alison L. Bailey, MD, FACC discuss their top takeaways from 2021 in heart failure and preventive cardiology. These ACCEL Leaders discuss new data regarding SGLT2is, the association of SGLT2i and quality of life measured by KCCQ strata and done so in an entirely virtual space. These are major new data points and infer intriguing new ways to generate original data. What is the message for implementation and cost? Dive into new aspirin data and guidance, COVID myocarditis, and the STEP and ORION trials in this episode.     Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Increasing the number of physicians who are Black, Hispanic/Latinx, and Indigenous benefits everyone in the US, but it cannot be the sole responsibility of historically Black colleges and universities (HBCUs). Valerie Montgomery Rice, MD, president and dean of Morehouse School of Medicine (MSM), and Clyde W. Yancy, MD, of Northwestern Medicine, join JAMA Editor in Chief Howard Bauchner, MD, to discuss options for developing training pipelines of underrepresented minority health science students, and how academic medicine can make racial justice a part of its work and mission. Recorded January 5, 2021. Related Article: Academic Medicine and Black Lives Matter

ACCEL Associate Editors Clyde W. Yancy, MD, FACC, and C. Noel Bairey Merz, MD, FACC, chat with Editor in Chief Alison L. Bailey, MD, FACC, about their top takeaways from 2020 in heart failure and prevention.

Clyde W. Yancy, MD, MSc, discusses the increased risk faced by patients with COVID-19 and cardiovascular disease, COVID-19 as it relates to ACE inhibitors and ARBs, racial disparity in COVID-19 cases, and other topics related to treating cardiovascular patients during the COVID-19 pandemic.

Clyde W. Yancy MD, MSc discusses high-level treatment options for heart failure based on the ACC/AHA heart failure guidelines. He shares that heart failure is not inevitable but can be indeed prevented. He examines why the SGLT2-inhibitor story is exciting, how it came about and what the practitioner should do today with this new information.

When did heart failure become sexy?Clyde W. Yancy MD joins the podcast to discuss what is new with heart failure, whether it can be prevented and how Northwestern Memorial Hospital is taking the lead in heart failure care.

Clyde W. Yancy, MD interviews Sripal Bangalore, MD, MHA, author of Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting, James M. McCabe, MD, author of Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York, and Ajay J. Kirtane, MD, SM, author of The Complicated Calculus of Publicly Reporting Mortality After Percutaneous Coronary Intervention